Empowered Funds LLC raised its holdings in shares of CRH plc (NYSE:CRH - Free Report) by 397.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 52,932 shares of the construction company's stock after acquiring an additional 42,302 shares during the period. Empowered Funds LLC's holdings in CRH were worth $4,909,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in CRH. GHP Investment Advisors Inc. raised its holdings in CRH by 336.4% during the second quarter. GHP Investment Advisors Inc. now owns 336 shares of the construction company's stock worth $25,000 after purchasing an additional 259 shares in the last quarter. Deseret Mutual Benefit Administrators acquired a new position in shares of CRH during the 3rd quarter valued at $25,000. UMB Bank n.a. raised its stake in shares of CRH by 72.7% in the 3rd quarter. UMB Bank n.a. now owns 297 shares of the construction company's stock worth $28,000 after buying an additional 125 shares in the last quarter. Baillie Gifford & Co. lifted its holdings in shares of CRH by 70.7% in the third quarter. Baillie Gifford & Co. now owns 391 shares of the construction company's stock valued at $36,000 after buying an additional 162 shares during the period. Finally, Rothschild Investment LLC bought a new position in CRH during the second quarter valued at about $43,000. Institutional investors and hedge funds own 62.50% of the company's stock.
Wall Street Analyst Weigh In
CRH has been the topic of a number of research reports. Truist Financial boosted their target price on shares of CRH from $110.00 to $120.00 and gave the stock a "buy" rating in a report on Friday, November 8th. Hsbc Global Res raised CRH to a "strong-buy" rating in a research note on Monday, November 11th. StockNews.com raised shares of CRH from a "hold" rating to a "buy" rating in a research note on Monday, November 11th. Morgan Stanley lifted their target price on shares of CRH from $95.00 to $104.00 and gave the company an "overweight" rating in a research note on Monday, November 11th. Finally, Barclays began coverage on shares of CRH in a report on Tuesday, October 29th. They set an "overweight" rating and a $110.00 price target for the company. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, CRH has a consensus rating of "Buy" and a consensus target price of $105.55.
Check Out Our Latest Research Report on CRH
CRH Price Performance
Shares of CRH stock traded up $1.36 during midday trading on Monday, hitting $99.65. 3,124,686 shares of the company were exchanged, compared to its average volume of 4,875,146. The firm has a 50 day simple moving average of $92.77 and a 200-day simple moving average of $84.97. CRH plc has a 52 week low of $58.57 and a 52 week high of $102.51. The firm has a market cap of $67.68 billion, a P/E ratio of 19.66, a PEG ratio of 1.43 and a beta of 1.29.
CRH Cuts Dividend
The company also recently announced a Variable dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Friday, November 22nd will be paid a $0.262 dividend. The ex-dividend date of this dividend is Friday, November 22nd. This represents a dividend yield of 1.4%. CRH's dividend payout ratio is presently 32.00%.
CRH Profile
(
Free Report)
CRH plc, together with its subsidiaries, provides building materials solutions in Ireland and internationally. It operates through four segments: Americas Materials Solutions, Americas Building Solutions, Europe Materials Solutions, and Europe Building Solutions. The company provides solutions for the construction and maintenance of public infrastructure and commercial and residential buildings; and produces and sells aggregates, cement, readymixed concrete, and asphalt, as well as provides paving and construction services.
Featured Articles
Before you consider CRH, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CRH wasn't on the list.
While CRH currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.